Microcautery for the Treatment of Spider Leg Veins

Assiut University

Status: Unknown

Conditions: Microcautery for Leg Veins

Treatments: Device: Mole Freckle Pen

Study type: Interventional

Funder types: Other

Identifiers

NCT04072172

Micro-cautery for leg veins

Details and patient eligibility

About

To Evaluate the role of micro-cauterization use in the treatment and disappearance of spider leg veins.

Full description

Spider veins on the lower limbs are very common and have been reported to be presented in 41% of women over 50 years old. Sclerotherapy as a traditional treatment for spider veins has a low cost, though it may have adverse sequelae. Lasers have shown fewer but still substantial complications as well.1 Spider veins are small superficial veins that widen and become visible, often on the legs and most cutaneous spider veins are abnormalities of the horizontal vascular skin plexus or capillary loops.2 Spider leg veins are composed of a feeder vessel and ectatic venous sprouts in the reticular dermis. Their depth is between 180 µm and 1 mm in the skin.3 Spider veins may have a diameter that reaches several millimetres and can be blue, purple or red and may appear in the form of thin lines, webs or branches.4 There is a scarce available data from literature about the role of micro-cauterization in the treatment of spider veins. The micro-cauterization is an alternative in management of spider veins that delivered via Mole Freckle Pen German Technology.4 Cautery is a safe and effective tool for the treatment of superficial and small skin lesions. It is simple, cheap, and requires minimal training and the results are usually satisfactory Technology Specifications with insulated micro steel needle use current: 5V / 1A of 5-speed free adjustment.5 The current study aims to evaluate the role for micro-cauterization in the treatment and disappearance of spider leg veins.

Enrollment: 20 estimated patients

Sex: Female

Ages: 20 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• were patients with spider veins of less than 2.0 mm in diameter.

Exclusion criteria

• were patients with diabetes, anticoagulation therapy and/or patients with a known history of keloids

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

Female with leg spider veins

Experimental group

Description:

Females at the age of 20 to 45 not known diabetics or hypertensive complaining of leg spider veins.

Treatment:

Device: Mole Freckle Pen